Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Aethlon Medical's revenue for the twelve months ending Mar 31, 2023 was $574.25K, up 95.2% year over year. For fiscal 2024 it was $0, down 100.0% from the year before. The highest annual figure on record is $1.62M in fiscal 2014.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Mar 31, 2024 | $0 | -100.0% |
| FY2023 | Mar 31, 2023 | $574.25K | +95.2% |
| FY2022 | Mar 31, 2022 | $294.17K | -55.4% |
| FY2021 | Mar 31, 2021 | $659.10K | +1.4% |
| FY2020 | Mar 31, 2020 | $650.19K | +183.2% |
| FY2019 | Mar 31, 2019 | $229.63K | +53.5% |
| FY2018 | Mar 31, 2018 | $149.63K | -61.8% |
| FY2017 | Mar 31, 2017 | $392.07K | -55.8% |
| FY2016 | Mar 31, 2016 | $886.57K | +16.3% |
| FY2015 | Mar 31, 2015 | $762.42K | -53.0% |
| FY2014 | Mar 31, 2014 | $1.62M | +32.0% |
| FY2013 | Mar 31, 2013 | $1.23M | -9.5% |
| FY2012 | Mar 31, 2012 | $1.36M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $574.25K | +4278.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $0 | -100.0% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $0 | -100.0% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $0 | -100.0% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $13.12K | -61.7% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $17.12K | -97.3% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $131.97K | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $131.97K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $34.23K | -83.4% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $624.87K | +51.1% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $0 | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $0 | -100.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $206.73K | +158.4% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $413.46K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $0 | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $30.00K | -79.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $80.00K | +6.9% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $0 | -100.0% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $0 | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $149.63K | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $74.81K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $74.81K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $0 | -100.0% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $0 | -100.0% |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $0 | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $0 | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $387.44K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | $4.64K | – |
See a number that looks wrong?